Modeling inhalational tularemia: deliberate release and public health response.

Authors:
Address: Emergency Response Department, Health Protection Agency, Salisbury, England, UK. joseph.egan@hpa.org.uk
Journal:


Publication:

abstract

Two epidemic Modeling studies of inhalational tularemia were identified in the published literature, both demonstrating the high number of potential casualties that could result from a deliberate aerosolized release of the causative agent in an urban setting. However, neither study analyzed the natural history of inhalational tularemia nor modeled the relative merits of different mitigation strategies. We first analyzed publicly available human/primate experimental data and reports of naturally acquired inhalational tularemia cases to better understand the epidemiology of the disease. We then simulated an aerosolized release of the causative agent, using airborne dispersion modeling to demonstrate the potential number of casualties and the extent of their spatial distribution. Finally, we developed a public health intervention model that compares 2 mitigation strategies: targeting antibiotics at symptomatic individuals with or without mass distribution of antibiotics to potentially infected individuals. An antibiotic stockpile that is sufficient to capture all areas where symptomatic individuals were infected is likely to save more lives than treating symptomatic individuals alone, providing antibiotics can be distributed rapidly and their uptake is high. However, with smaller stockpiles, a strategy of treating symptomatic individuals alone is likely to save many more lives than additional mass distribution of antibiotics to potentially infected individuals. The spatial distribution of symptomatic individuals is unlikely to coincide exactly with the path of the dispersion cloud if such individuals are infected near their work locations but then seek treatment close to their homes. The optimal mitigation strategy will depend critically on the size of the release relative to the stockpile level and the effectiveness of treatment relative to the speed at which antibiotics can be distributed.

© Mary Ann Liebert, Inc.



Related Articles
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program. Rep Carcinog Backgr Doc. 2010 Jan; (10-5981):i-512.
Review Tularemia: the disease and the weapon.
Dermatol Clin. 2004
Review Tularemia: the disease and the weapon.
Cronquist SD. Dermatol Clin. 2004 Jul; 22(3):313-20, vi-vii.
Re-assessment of mitigation strategies for deliberate releases of anthrax using a real-time outbreak characterization tool.
Epidemics. 2010
Re-assessment of mitigation strategies for deliberate releases of anthrax using a real-time outbreak characterization tool.
Egan JR, Legrand J, Hall IM, Cauchemez S, Ferguson NM, Leach S. Epidemics. 2010 Dec; 2(4):189-94. Epub 2010 Jun 10.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program. Rep Carcinog Backgr Doc. 2008 Sep; (8-5978):i-398.
Review Tularemia as a biological weapon: medical and public health management.
JAMA. 2001
Review Tularemia as a biological weapon: medical and public health management.
Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, et al. JAMA. 2001 Jun 6; 285(21):2763-73.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.